Oral 5-FU+/-bevacizumab should be basically used for first-line chemotherapy for elderly colorectal cancerous patients
Kazuma Kobayashi,Kunihito Matsuguma,Yusuke Inoue,Satomi Okada,Toshiyuki Adachi,Shun Nakamura,Shinichiro Kobayashi,Yasuhiro Maruya,Ryo Matsumoto,Taiichiro Kosaka,Sayaka Kuba,Michi Morita,Takanobu Hara,Hajime Imamura,Akihiko Soyama,Tomohiko Adachi,Shinichiro Ito,Masaaki Hidaka,Kengo Kanetaka,Susumu Eguchi ANNALS OF ONCOLOGY（2023）
AI 理解论文
溯源树
样例
